Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease Progression
- PMID: 36247907
- PMCID: PMC9547146
- DOI: 10.1002/mdc3.13511
Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease Progression
Abstract
Background: Parkinson's disease (PD), with either rapid eye movement sleep behavior disorder (RBD) or olfactory dysfunction (OD), has been associated with disease progression. However, there is currently heterogeneity in predicting prognosis.
Objectives: To identify whether the concurrent presence of OD and probable RBD (pRBD) in PD (Dual hit in PD, PD-DH) is associated with disease progression.
Methods: We included 420 patients with de novo PD from the Parkinson's Progression Markers Initiative: 180 PD only (PD), 82 PD with OD (PD-OD), 94 PD with pRBD (PD-pRBD), and 64 PD with both OD and pRBD (PD-DH). Participants underwent motor and nonmotor evaluations, dopamine transporter imaging, and cerebrospinal fluid (CSF) assessment. Data were analyzed with generalized estimating equations and Cox proportional hazards analysis.
Results: The PD-DH subtype was associated with higher scores and faster progression rates in Movement Disorder Society-Unified PD Rating Scale (MDS-UPDRS) Parts II and III. Also, patients in PD-DH group had faster deterioration in nonmotor symptoms, including MDS-UPDRS Part I score, Montreal Cognitive Assessment, Hopkins Verbal Learning Test-Revised, Wechsler Memory Scale-Third edition (WMS-III) Letter Number Sequencing score, Symbol Digit Modalities Test, and Scales for Outcomes in PD-Autonomic scores, with all P values <0.002. Moreover, the PD-DH subtype had a higher mild cognitive impairment risk (hazard ratio = 1.756, 95% confidence interval [CI] = 1.132-2.722; P = 0.012), faster decline in caudate standard uptake values (β = -0.03, 95% CI = -0.06 to -0.008, P = 0.012), and CSF α-synuclein levels (β = -77, 95% CI = -149 to -5, P = 0.034) than the PD group.
Conclusion: Coexisting pRBD and OD in patients with PD may be associated with faster progressions in motor measurements and in cognitive and autonomic symptoms, indicating PD-DH as a more aggressive subtype for PD.
Keywords: Parkinson's disease; REM sleep behavior disorder; cognitive function; motor progression; olfactory dysfunction.
© 2022 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC. on behalf of International Parkinson and Movement Disorder Society.
Similar articles
-
Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.Mov Disord. 2021 Dec;36(12):2821-2832. doi: 10.1002/mds.28763. Epub 2021 Aug 26. Mov Disord. 2021. PMID: 34448251
-
Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.PLoS One. 2021 Feb 19;16(2):e0247443. doi: 10.1371/journal.pone.0247443. eCollection 2021. PLoS One. 2021. PMID: 33606814 Free PMC article.
-
Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder.Front Neurol. 2020 Sep 11;11:979. doi: 10.3389/fneur.2020.00979. eCollection 2020. Front Neurol. 2020. PMID: 33041969 Free PMC article.
-
Impact of rapid eye movement sleep behavior disorder and autonomic disorders on Parkinson's disease: a review.Arq Neuropsiquiatr. 2021 Feb;79(2):156-166. doi: 10.1590/0004-282X-anp-2020-0173. Arq Neuropsiquiatr. 2021. PMID: 33759983 Review.
-
Risk stratification for REM sleep behavior disorder in patients with Parkinson's disease: A PRISMA-compliant meta-analysis and systematic review.Clin Neurol Neurosurg. 2021 Mar;202:106484. doi: 10.1016/j.clineuro.2021.106484. Epub 2021 Jan 12. Clin Neurol Neurosurg. 2021. PMID: 33556851
Cited by
-
Definition and diagnosis of Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology.J Neurol. 2024 Nov;271(11):7102-7119. doi: 10.1007/s00415-024-12687-5. Epub 2024 Sep 19. J Neurol. 2024. PMID: 39297986 Free PMC article.
References
-
- Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB, the MDS Task Force on the Definition of Parkinson's Disease . Update of the MDS research criteria for prodromal Parkinson's disease. Mov Disord 2019;34(10):1464–1470. - PubMed
-
- Fereshtehnejad SM, Romenets SR, Anang JB, et al. New clinical subtypes of Parkinson disease and their longitudinal progression: A prospective cohort comparison with other phenotypes. JAMA Neurol 2015;72(8):863–873. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous